Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study - Concepedia

Concepedia

Publication | Closed Access

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study

23

Citations

31

References

2017

Year

Mette S. van Ramshorst, Erik van Werkhoven, Ingrid A.M. Mandjes, Margaret Schot, Jelle Wesseling, Marie-Jeanne T.F.D. Vrancken Peeters, Jetske M. Meerum Terwogt, Monique E.M.M. Bos, Hendrika M. Oosterkamp, Sjoerd Rodenhuis,

European Journal of Cancer

Breast OncologyOncologyWeekly PaclitaxelBreast CancerNeo-adjuvant TreatmentCancer TreatmentMedicineRadiation OncologyHer2-positive Breast Cancer

References

	Year	Citations

Page 1

Page 1